Register entryShortage reported
Vertical Pharmaceuticals, LLC
- Registered sites
- 0
- Drug products
- 15
- Live patents
- 21
- Countries
- 0
- Base
- Unknown
Sites
Facilities
0No registered facilities
This company holds drug listings or approvals but operates no registered establishment of its own, which is normal for an NDA holder that outsources manufacturing.
Alert
Products in shortage
11| Drug | Presentation | Availability |
|---|---|---|
| Methylphenidate Hydrochloride Tablet, Extended Release | Relexxii, Tablet, Extended Release, 54 mg (NDC 68025-098-30) | Available |
| Methylphenidate Hydrochloride Tablet, Extended Release | Relexxii, Tablet, Extended Release, 18 mg (NDC 68025-095-10) | Available |
| Methylphenidate Hydrochloride Tablet, Extended Release | Relexxii, Tablet, Extended Release, 18 mg (NDC 68025-095-30) | Available |
| Methylphenidate Hydrochloride Tablet, Extended Release | Relexxii, Tablet, Extended Release, 36 mg (NDC 68025-097-10) | Available |
| Methylphenidate Hydrochloride Tablet, Extended Release | Relexxii, Tablet, Extended Release, 36 mg (NDC 68025-097-30) | Available |
| Methylphenidate Hydrochloride Tablet, Extended Release | Relexxii, Tablet, Extended Release, 27 mg (NDC 68025-096-30) | Available |
| Methylphenidate Hydrochloride Tablet, Extended Release | Relexxii, Tablet, Extended Release, 27 mg (NDC 68025-096-10) | Available |
| Methylphenidate Hydrochloride Tablet, Extended Release | Relexxii, Tablet, Extended Release, 63 mg (NDC 68025-089-30) | Available |
| Methylphenidate Hydrochloride Tablet, Extended Release | Relexxii, Tablet, Extended Release, 72 mg (NDC 68025-084-30) | Available |
| Methylphenidate Hydrochloride Tablet, Extended Release | Relexxii, Tablet, Extended Release, 54 mg (NDC 68025-098-10) | Available |
| Methylphenidate Hydrochloride Tablet, Extended Release | Relexxii, Tablet, Extended Release, 45 mg (NDC 68025-088-30) | Available |
Exclusivity
Patents
21Unexpired Orange Book patents where this company is the application holder.
| Product | Active ingredient | Expiry |
|---|---|---|
| DSUVIA | SUFENTANIL CITRATE | Jan 2027 |
| DSUVIA | SUFENTANIL CITRATE | Mar 2030 |
| DSUVIA | SUFENTANIL CITRATE | Oct 2030 |
| DSUVIA | SUFENTANIL CITRATE | Jul 2031 |
| DSUVIA | SUFENTANIL CITRATE | Feb 2038 |
Catalogue
Marketed products
15Showing 15 of 15.
| Brand | Generic name | Form | Category |
|---|---|---|---|
| ConZip | tramadol hydrochloride | CAPSULE, EXTENDED RELEASE | NDA |
| ConZip | tramadol hydrochloride | CAPSULE, EXTENDED RELEASE | NDA |
| ConZip | tramadol hydrochloride | CAPSULE, EXTENDED RELEASE | NDA |
| DIVIGEL | estradiol | GEL | NDA |
| DIVIGEL | estradiol | GEL | NDA |
| DIVIGEL | estradiol | GEL | NDA |
| DIVIGEL | estradiol | GEL | NDA |
| DIVIGEL | estradiol | GEL | NDA |
| RELEXXII | methylphenidate hydrochloride | TABLET, EXTENDED RELEASE | NDA |
| RELEXXII | methylphenidate hydrochloride | TABLET, EXTENDED RELEASE | NDA |
| RELEXXII | methylphenidate hydrochloride | TABLET, EXTENDED RELEASE | NDA |
| RELEXXII | methylphenidate hydrochloride | TABLET, EXTENDED RELEASE | NDA |
| RELEXXII | methylphenidate hydrochloride | TABLET, EXTENDED RELEASE | NDA |
| RELEXXII | methylphenidate hydrochloride | TABLET, EXTENDED RELEASE | NDA |
| RELEXXII | methylphenidate hydrochloride | TABLET, EXTENDED RELEASE | NDA |
Provenance
Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.